HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Stefan Christiansen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Christiansen, S. Search for Related Content PubMed PubMed Citation Articles by Christiansen, S. Related Collections Transplantation - heart

J Thorac Cardiovasc Surg 2004;127:302-303
© 2004 The American Association for Thoracic Surgery

Letter to the editor

Partial left ventriculectomy in patients with neoplasms and severe heart failure who are not candidates for cardiac transplantation

Department of Cardiothoracic Surgery, University of Aachen, Aachen, Germany

The first 20% of the full text of this article appears below.

To the Editor:

I read the article of Casarotto and colleagues¹ with great interest. The article described a patient with Castleman disease who was treated with chemotherapy, leading to a dilated cardiomyopathy. Because of the neoplasm, cardiac transplantation was contraindicated. Because of a progredient severe heart failure, the patient had to be supported with a Novacor (World Heart Corporation, Ottawa, Ontario, Canada) left ventricular assist device (LVAD). After a total of 1512 days, the patient had no signs of a relapse of Castleman disease . . . [Full Text of this Article]

This article has been cited by other articles:

				S. Christiansen and R. Autschbach Doxorubicin in experimental and clinical heart failure Eur J Cardiothorac Surg, October 1, 2006; 30(4): 611 - 616. [Abstract] [Full Text] [PDF]